StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) shareholders

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.1%
0M of 12M shares
Institutional holders
3
1 new, 1 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $728.80K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Choo Chee Kong3,003,99625.17%13D (active) amendmentOct 12, 2026
mDR LTD1,191,5239.98%13G (passive) amendmentOct 12, 2026
Wang Shu883,8587.66%13G (passive)Feb 14, 2024
28 Consultants Ltd880,3137.62%13G (passive)Feb 17, 2025
Zeng Jieming589,2395.11%13G (passive)Feb 14, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of GDTCValueChange% of portfolio
Axiom Investment Management LLC7,0320.06%$7.24KNew0.00%
UBS Group AG4,8310.04%$4.98K−1,3510.00%
Osaic Holdings, Inc.210.00%$21–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202630M0.1%1 / 01 / 10M0M
Q1 202630M0.1%1 / 10 / 30M0M
Q4 202550M0.4%4 / 01 / 10M0M
Q3 202520M0.2%1 / 01 / 10M0M
Q2 202520M0.4%0 / 20 / 00M0M
Q1 202520M0.3%1 / 10 / 00M0M
Q4 202410M0.1%0 / 10 / 00M0M
Q3 202410M0.0%1 / 00 / 00M0M
Q2 202400M0.0%0 / 00 / 10M0M
Q1 202410M0.0%0 / 01 / 10M0M
Q4 202320M0.0%1 / 10 / 10M0M
Q3 202320M0.0%1 / 10 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Yvonne GohChief Financial Officer25,7810.22%May 15, 2026
Yoong Ying TanChief Corporate Officer25,7810.22%May 15, 2026
Chee Kong ChooDirector, 10% owner2,899,74624.52%Jul 24, 2026
Keng Kiat TohDirector4,0000.03%May 26, 2026
Mark Kei Wei LeongDirector––May 15, 2026
Chak Hua YewDirector2,4690.02%May 15, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Chee Kong Choo
Director, 10% owner
Jul 20, 2026Buy+100,000$1.50$150.00K630,324
Chee Kong Choo
Director, 10% owner
Jul 20, 2026Buy−100,000$1.50$150.00K630,324
Chee Kong Choo
Director, 10% owner
Jul 14, 2026Buy+100,000$1.50$150.00K530,324
Chee Kong Choo
Director, 10% owner
Jul 14, 2026Buy−100,000$1.50$150.00K530,324
Chee Kong Choo
Director, 10% owner
May 13, 2026Buy+112,000$1.15$128.80K430,324

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.8
At 0M shares a day
Change since last report
-9.0%
From 0M shares
Short volume, 20 days
40.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of CytoMed Therapeutics's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
mDR Ltd
10% Stockholder
Aug 11, 2026117,337$103.26KAug 11, 2026Share Subscription
mDR LTD
10% Stockholder
May 13, 2026117,337$98.09KMay 13, 2026Share Subscription
mDR LTD
10% Stockholder
Feb 12, 2026117,337$122.03KFeb 12, 2026Share Subscription
mDR Ltd
10% Stockholder
Sep 22, 202554,644$102.73KSep 23, 2025Share Subscription
mDR Ltd
10% Stockholder
Jun 23, 202581,482$171.11KJun 23, 2025Share Subscription
mDR Ltd
10% Stockholder
Mar 24, 202586,410$229.85KMar 24, 2025Share Subscription
mDR Ltd
10% Stockholder
Nov 4, 2024115,400$266.00KNov 5, 2024Share Subscription

See a number that looks wrong?